Clinical Trial Update: A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis

View source ↗

Summary

A study evaluating switching from ustekinumab to guselkumab in adults with moderate-to-severe psoriasis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Guselkumab (guselkumab)
• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Psoriasis | Status: RECRUITING